Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease

CONCLUSION: Cinacalcet was dominant to avoid parathyroidectomies, being cost-effective.PMID:37015047 | DOI:10.1590/2175-8239-JBN-2022-0126en

Source: Jornal Brasileiro de Nefrologia - April 4, 2023 Category: Urology & Nephrology Authors: Daniela Ponce Marilia Mastrocolla de Almeida Cardoso Juliana Rodrigues Machado R úgolo Silvana Andrea Molina Luis Gustavo Modelli de Andrade Daniel da Silva Pereira Curado Source Type: research